Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Lists
Only you see this
Abstract
Hairy cell leukemia (HCL) is a rare type of indolent B-cell leukemia, characterized by symptoms of fatigue and weakness, organomegaly, pancytopenia, and recurrent opportunistic infections. Classic HCL should be considered a distinct clinical entity separate from HCLvariant (HCLv), which is associated with a more aggressive disease course and may not respond to standard HCL therapies. Somatic hypermutation in the <i>IGHV</i> gene is present in most patients with HCL. The <i>BRAF</i> V600E mutation has been reported in most patients with classic HCL but not in those with other B-cell leukemias or lymphomas. Therefore, it is necessary to distinguish HCLv from classic HCL. This manuscript discusses the recommendations outlined in the NCCN Guidelines for the diagnosis and management of classic HCL.
BibTeX
@article{wierda2017hairy,
author = {William G. Wierda and John C. Byrd and Jeremy S. Abramson and Seema A. Bhat and Greg Bociek and Danielle M. Brander and Jennifer R. Brown and Asher Chanan‐Khan and Steven Coutré and Randall S. Davis and Christopher D.�M. Fletcher and Brian L. Hill and Brad S. Kahl and Manali Kamdar and Lawrence D. Kaplan and Nadia Khan and Thomas J. Kipps and Jeffrey E. Lancet and Shuo Ma and Sami N. Malek and Claudio A. Mosse and Mazyar Shadman and Tanya Siddiqi and Deborah M. Stephens and Nina Wagner and Andrew D. Zelenetz and Mary A. Dwyer and Hema Sundar},
title = {{Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology}},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2017},
doi = {10.6004/jnccn.2017.0165},
}Loading related content...